Intravenous Anesthetic Diazepam Does Not Induce Amyloid-beta Peptide Oligomerization but Diazepam Co-administered with Halothane Oligomerizes Amyloid-beta Peptide: An NMR Study

Neurospectroscopy and Neuroimaging Laboratory, National Brain Research Center, Manesar, Gurgaon, India.
Journal of Alzheimer's disease: JAD (Impact Factor: 4.15). 02/2010; 20(1):127-34. DOI: 10.3233/JAD-2010-1350
Source: PubMed


Amyloid-beta peptide (Abeta) oligomerization has a profound role in Alzheimer's disease pathophysiology. Biophysical studies have shown that smaller sized inhaled anesthetics promote oligomerization by inducing perturbation of three critical amino acid residues (G29, A30, and I31) located in the helix-loop-helix domain of Abeta. In this present experimental study, using state-of-the-art nuclear magnetic resonance, we have monitored the influence of a larger sized intravenous anesthetic, diazepam, as well as diazepam co-administered with halothane, on Abeta. It was concluded that diazepam (in isolation) does not interact with the G29, A30, and I31 residues, and no Abeta oligomerization occurs in the presence of 0.101 mM diazepam, even after 63 days. However, when diazepam was co-administered with halothane, profound Abeta oligomerization is observed. These results strengthen the hypothesis that the presence of smaller molecular sized anesthetic is instrumental in promoting Abeta oligomerization even when co-administered with a larger sized anesthetic, namely diazepam.

Download full-text


Available from: Virgil Simplaceanu
  • Source
    • "Nuclear magnetic resonance (NMR) is an important biophysical method for the in vitro determination of protein structure and protein–drug interaction studies [1] [2] [3]. Magnetic Resonance Imaging (MRI), based on the principles of NMR, is a powerful noninvasive biomedical application tool (in vivo) to visualize different regions of the body which provides greater image contrast between normal and abnormal tissues (e.g. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Magnetic resonance spectroscopy (MRS) is a non-invasive imaging modality for metabolite detection in different parts of the body (e.g. brain, liver, prostate, breast, kidney, skeletal muscle, and heart) for normal person as well as in various disorders. It aids in providing valuable information for both diagnosis as well as therapeutic monitoring. Though there has been tremendous progress in MRS signal processing techniques for the quantitation of neurometabolites, variability in the absolute quantitation of metabolites persists due to various experimental conditions. In this article, we present in-depth discussion on (1)H MRS data processing and quantitation using different software packages both in frequency (e.g. LCModel) and time domain (e.g. jMRUI). We have included comparative analysis of precision and accuracy of MRS data processing using LCModel and jMRUI (AMARES). Special emphasis has been provided for the handling of macromolecules and lipid in LCModel and jMRUI methods. The author also suggests certain points to be noted while opting for above software packages.
    Full-text · Article · Apr 2011 · European journal of radiology
  • Source
    • "Experimental findings suggest that certain anesthetic molecules can, in laboratory models, induce changes in protein expression in the brain of animals [16] [17]. This research has led to many important findings notably that smaller sized, inhaled anesthetics oligomerize Aβ peptide [18] [19] [20] [21] and increase other proteins which have been shown to play a role in AD [22] [23]. AD is a devastating disease. "

    Full-text · Article · Oct 2010 · Journal of Alzheimer's disease: JAD
  • Source
    • "Finally , studies have been conducted also on intravenous anesthetics, highlighting how propofol, at very high concentrations, induces oligomerization, while clinical concentrations of propofol inhibit it [4] [66]. Similarly thiopentone, also at high concentrations, does not interact with Aβ, which remains in its monomeric form [67] [68]. Propofol and thiopental can, therefore, be considered relatively safe [69]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the accumulation and aggregation of amyloid-β peptide and loss of forebrain cholinergic neurons, resulting in progressive loss of memory and irreversible impairment of higher cognitive functions. Several studies have accounted for the close relationship between AD and the central cholinergic system, suggesting that a dysfunction of acetylcholine containing neurons in the brain contributes significantly to the cognitive deficit of individuals with AD. The aim of the present review is to survey current literature on this topic in order to provide a clear understanding of the role of the cholinergic system in the development and neurodegenerative process of AD. The implications for anesthesia are also discussed. This knowledge could be valuable to improve anesthesia performance and patient safety.
    Full-text · Article · Jan 2010 · Journal of Alzheimer's disease: JAD
Show more